International Assets Investment Management LLC Boosts Holdings in Humana Inc. (NYSE:HUM)

International Assets Investment Management LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 32,648.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 134,596 shares of the insurance provider’s stock after acquiring an additional 134,185 shares during the period. International Assets Investment Management LLC’s holdings in Humana were worth $61,619,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Gradient Investments LLC raised its stake in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares during the period. Nvwm LLC grew its position in Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after acquiring an additional 25 shares during the period. Operose Advisors LLC acquired a new stake in Humana during the third quarter worth about $56,000. Bruce G. Allen Investments LLC acquired a new stake in Humana during the fourth quarter worth about $84,000. Finally, Grove Bank & Trust raised its holdings in shares of Humana by 503.4% in the 3rd quarter. Grove Bank & Trust now owns 175 shares of the insurance provider’s stock worth $85,000 after purchasing an additional 146 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. StockNews.com downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Argus cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Bank of America reissued a “neutral” rating and issued a $342.00 price objective (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Oppenheimer decreased their target price on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Finally, Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating and dropped their target price for the company from $595.00 to $360.00 in a report on Thursday, January 25th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $424.50.

Insider Buying and Selling

In related news, Director Jorge S. Mesquita bought 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the acquisition, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.32% of the stock is owned by company insiders.

Humana Price Performance

HUM opened at $320.98 on Friday. The company has a market capitalization of $38.68 billion, a P/E ratio of 19.99, a PEG ratio of 1.76 and a beta of 0.50. The company has a 50-day moving average of $324.67 and a 200-day moving average of $389.56. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $541.21.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the business posted $9.38 EPS. Equities analysts expect that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.